Enhanced vascular VCAM-1+ immune-reactivity in response to SAA is indicative of endothelial dysfunction and this may manifest as decreased bioavailability/bioactivity of vasodilating nitric oxide (NO). Here, SAA2 is linked to endothelial dysfunction.